|
|
Prepublished online as a Blood First Edition Paper on October 10, 2002; DOI 10.1182/blood-2002-05-1329.
Previous Article | Table of Contents | Next Article 
Blood, 15 February 2003, Vol. 101, No. 4, pp. 1367-1374
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Modulation of VEGFR-2-mediated endothelial-cell
activity by VEGF-C/VEGFR-3
Kazuyoshi Matsumura,
Masanori Hirashima,
Minetaro Ogawa,
Hajime Kubo,
Hiroshi Hisatsune,
Nobuyuki Kondo,
Satomi Nishikawa,
Tsutomu Chiba, and
Shin-Ichi Nishikawa
From the Division of Gastroenterology and Hepatology,
Department of Internal Medicine, Graduate School of Medicine, Kyoto
University, Kyoto, Japan; the Department of Molecular
Genetics, Graduate School of Medicine, Kyoto University, Kyoto,
Japan; and the Stem Cell Biology Laboratory, Center for
Developmental Biology, Kobe, Japan.
Vascular endothelial growth factor (VEGF) receptor 3 (VEGFR-3), a
receptor for VEGF-C, was shown to be essential for angiogenesis as well
as for lymphangiogenesis. Targeted disruption of the
VEGFR-3 gene in mice and our previous study using an
antagonistic monoclonal antibody (MoAb) for VEGFR-3 suggested that
VEGF-C/VEGFR-3 signals might be involved in the maintenance of vascular
integrity. In this study we used an in vitro embryonic stem (ES) cell
culture system to maintain the VEGFR-3+ endothelial
cell (EC) and investigated the role of VEGFR-3 signals at the cellular
level. In this system packed clusters of ECs were formed. Whereas
addition of exogenous VEGF-A induced EC dispersion, VEGF-C, which can
also stimulate VEGFR-2, promoted EC growth without disturbing the EC
clusters. Moreover, addition of AFL4, an antagonistic MoAb for VEGFR-3,
resulted in EC dispersion. Cytological analysis showed that VEGF-A-
and AFL4-treated ECs were indistinguishable in many aspects but were
distinct from the cytological profile induced by antagonistic MoAb for
VE-cadherin (VECD-1). As AFL4- induced EC dispersion requires VEGF-A
stimulation, it is likely that VEGFR-3 signals negatively modulate
VEGFR-2. This result provides new insights into the involvement of
VEGFR-3 signals in the maintenance of vascular integrity through
modulation of VEGFR-2 signals. Moreover, our findings suggest that the
mechanisms underlying AFL4-induced EC dispersion are distinct from
those underlying VECD-1-induced dispersion for maintenance of EC integrity.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Kono, H. Kubo, C. Shimazu, Y. Ueda, M. Takahashi, K. Yanagi, N. Fujita, T. Tsuruo, H. Wada, and J. K. Yamashita
Differentiation of Lymphatic Endothelial Cells From Embryonic Stem Cells on OP9 Stromal Cells
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2006;
26(9):
2070 - 2076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Covassin, J. A. Villefranc, M. C. Kacergis, B. M. Weinstein, and N. D. Lawson
Distinct genetic interactions between multiple Vegf receptors are required for development of different blood vessel types in zebrafish
PNAS,
April 25, 2006;
103(17):
6554 - 6559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Hamaguchi, T. Morisada, M. Azuma, K. Murakami, M. Kuramitsu, T. Mizukami, K. Ohbo, K. Yamaguchi, Y. Oike, D. J. Dumont, et al.
Loss of Tie2 receptor compromises embryonic stem cell-derived endothelial but not hematopoietic cell survival
Blood,
February 1, 2006;
107(3):
1207 - 1213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Salameh, F. Galvagni, M. Bardelli, F. Bussolino, and S. Oliviero
Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways
Blood,
November 15, 2005;
106(10):
3423 - 3431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Morisada, Y. Oike, Y. Yamada, T. Urano, M. Akao, Y. Kubota, H. Maekawa, Y. Kimura, M. Ohmura, T. Miyamoto, et al.
Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation
Blood,
June 15, 2005;
105(12):
4649 - 4656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Suzuki, T. Watabe, M. Kato, K. Miyazawa, and K. Miyazono
Roles of vascular endothelial growth factor receptor 3 signaling in differentiation of mouse embryonic stem cell-derived vascular progenitor cells into endothelial cells
Blood,
March 15, 2005;
105(6):
2372 - 2379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Hicklin and L. M. Ellis
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
J. Clin. Oncol.,
February 10, 2005;
23(5):
1011 - 1027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Furuyama, K. Kitayama, Y. Shimoda, M. Ogawa, K. Sone, K. Yoshida-Araki, H. Hisatsune, S.-i. Nishikawa, K. Nakayama, K. Nakayama, et al.
Abnormal Angiogenesis in Foxo1 (Fkhr)-deficient Mice
J. Biol. Chem.,
August 13, 2004;
279(33):
34741 - 34749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dixelius, T. Makinen, M. Wirzenius, M. J. Karkkainen, C. Wernstedt, K. Alitalo, and L. Claesson-Welsh
Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation Sites
J. Biol. Chem.,
October 17, 2003;
278(42):
40973 - 40979.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|